Upgrade to SI Premium - Free Trial

William Blair Reiterates Market Perform Rating on Sarepta Therapeutics (SRPT)

July 21, 2025 5:04 AM
William Blair analyst Sami Corwin reiterated a Market Perform rating on Sarepta Therapeutics (NASDAQ: SRPT).The analyst comments "Stock thoughts and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles